The role of plectin as a druggable target in papillary thyroid carcinoma: therapeutic potential of troglitazone

Yi-Chen Lv, Jie-Hao Zhou, Tie-Feng Shi, Yun-Fu Cui

Open source

DOI
10.3389/fimmu.2026.1789251
Published
2026-08-26
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1789251,
  title = {The role of plectin as a druggable target in papillary thyroid carcinoma: therapeutic potential of troglitazone},
  author = {Yi-Chen Lv and Jie-Hao Zhou and Tie-Feng Shi and Yun-Fu Cui},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1789251},
  url = {https://doi.org/10.3389/fimmu.2026.1789251}
}

RIS

TY  - JOUR
TI  - The role of plectin as a druggable target in papillary thyroid carcinoma: therapeutic potential of troglitazone
AU  - Yi-Chen Lv
AU  - Jie-Hao Zhou
AU  - Tie-Feng Shi
AU  - Yun-Fu Cui
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1789251
UR  - https://doi.org/10.3389/fimmu.2026.1789251
ER  - 

APA

Lv, Y., Zhou, J., Shi, T., & Cui, Y. (2026). The role of plectin as a druggable target in papillary thyroid carcinoma: therapeutic potential of troglitazone. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1789251

Source records